These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 29353344

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF, Tsourdou A, Tzatzarakis MN, Tsika C, Charisis S, Naoumidi I, Plainis S, Tsilimbaris MK.
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dexamethasone delivery to the ocular posterior segment by sustained-release Laponite formulation.
    Prieto E, Cardiel MJ, Vispe E, Idoipe M, Garcia-Martin E, Fraile JM, Polo V, Mayoral JA, Pablo LE, Rodrigo MJ.
    Biomed Mater; 2020 Nov 21; 15(6):065021. PubMed ID: 32647098
    [Abstract] [Full Text] [Related]

  • 5. [Characteristic of ocular safety profile of triamcinolone made in China].
    Lan B, Hou J, Zhao C, Sun S, Li J, Cheng L.
    Zhonghua Yan Ke Za Zhi; 2014 Jul 21; 50(7):529-35. PubMed ID: 25312463
    [Abstract] [Full Text] [Related]

  • 6. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M, Li X, Liu J, Han Y, Cheng L.
    J Control Release; 2015 Apr 10; 203():109-17. PubMed ID: 25700623
    [Abstract] [Full Text] [Related]

  • 7. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F, Ramazzotti M, Vannozzi L, Rapizzi E, Fiore T, Iaccheri B, Degl' Innocenti D, Moncini D, Menchini U.
    Invest Ophthalmol Vis Sci; 2008 Mar 10; 49(3):1151-6. PubMed ID: 18326743
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ocular toxicity of intravitreal tacrolimus.
    Passos E, Genaidy MM, Peyman GA.
    Ophthalmic Surg Lasers; 2002 Mar 10; 33(2):140-4. PubMed ID: 11942546
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety of intravitreal clindamycin in albino rabbit eyes.
    Habot-Wilner Z, Mazza O, Shahar J, Massarweh A, Mann I, Loewenstein A, Perlman I.
    Doc Ophthalmol; 2017 Oct 10; 135(2):133-146. PubMed ID: 28744691
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Retinal toxicity of intravitreal kenalog in albino rabbits.
    Lang Y, Zemel E, Miller B, Perlman I.
    Retina; 2007 Oct 10; 27(6):778-88. PubMed ID: 17621190
    [Abstract] [Full Text] [Related]

  • 17. Ocular Safety of Intravitreal Connective Tissue Growth Factor Neutralizing Antibody.
    Motevasseli T, Daftarian N, Kanavi MR, Ahmadieh H, Bagheri A, Hosseini SB, Ansari S, Soheili ZS.
    Curr Eye Res; 2017 Aug 10; 42(8):1194-1201. PubMed ID: 28494166
    [Abstract] [Full Text] [Related]

  • 18. Intravitreal toxicity of garenoxacin.
    Esfahani MR, Kazi AA, Peyman GA, Dellacroce JT, Aydin E.
    Retina; 2006 Feb 10; 26(2):182-6. PubMed ID: 16467675
    [Abstract] [Full Text] [Related]

  • 19. Retinal toxicity of intravitreal trastuzumab in a rabbit model: preliminary results of an experimental study.
    Moschos MM, Chatziralli IP, Kalogeropoulos C, Georgountzos V, Agapitos E.
    J Ocul Pharmacol Ther; 2013 Oct 10; 29(8):754-9. PubMed ID: 23597072
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.